Search | Friends - Best Social Network - החברים

Devidi Jahnavi added blog Health
2025-06-23 12:17:24

mRNA Vaccines Redefined: CI Insights into Innovation, Platforms, and Market Expansion
Messenger RNA (mRNA) vaccines have emerged as a transformative force in the global fight against infectious diseases, with their rapid development, adaptability, and precision mechanism driving a new era of preventive medicine. Once considered experimental, mRNA technology now stands at the forefront of vaccine innovation, with expanding applications in infectious disease, oncology, and...

0 Comments 0 Shares 348 Views 0 Reviews

Please log in to like, share and comment!
Uttej Netha added blog Health
2025-06-27 09:45:32

USDA’s Poultry Vaccine Plan Accelerates USD 12B+ Veterinary Vaccines Industry
The global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD 18.56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile,...

0 Comments 0 Shares 380 Views 0 Reviews

Please log in to like, share and comment!
Kranthi Reddy added blog Health
2025-06-20 12:27:20

Global Immunization Growth Powers Live Attenuated Vaccine Demand
The Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across...

0 Comments 0 Shares 281 Views 0 Reviews

Please log in to like, share and comment!
Uttej Netha added blog Health
2025-06-30 07:33:24

Screening & Awareness Initiatives Bolster Hepatitis B Drug Uptake
The global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced...

0 Comments 0 Shares 114 Views 0 Reviews

Please log in to like, share and comment!